Profound Medical Corp. (PROF)
NASDAQ: PROF
· Real-Time Price · USD
4.26
-0.02 (-0.47%)
At close: May 13, 2025, 3:59 PM
4.27
0.23%
After-hours: May 13, 2025, 04:05 PM EDT
Profound Medical Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Capital Equipment Revenue | 2.44M |
| Capital Equipment Revenue Growth | n/a |
| Recurring - Non-Capital Revenue | 8.24M |
| Recurring - Non-Capital Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 6.6M | 6.64M | 5.08M | 4.82M | 5.87M | 4.21M | 4.33M | 4.21M | 3.77M | 4.59M | 5.03M | 4.55M | 5.53M | 4.54M | 4.18M | 3.72M | 3.45M | 3.03M | 2.67M | 3.04M | 2.99M | 2.21M | 2.09M | 737.54K | 1.5M | 2.06M | 2.55M | 1.74M | 2.01M | 1.88M | 2.02M | 1.7M | 1.48M | 968.64K | 913.74K | 868.1K | 605.15K | 819.22K | 2.73M | 10.77K |
| Selling, General, and Administrative Revenue Growth | -0.63% | +30.76% | +5.40% | -17.98% | +39.69% | -2.91% | +2.85% | +11.76% | -17.93% | -8.65% | +10.51% | -17.70% | +21.72% | +8.59% | +12.42% | +7.94% | +13.54% | +13.53% | -12.00% | +1.68% | +35.06% | +5.92% | +183.11% | -50.73% | -27.33% | -19.12% | +46.18% | -13.47% | +6.94% | -6.74% | +18.69% | +14.94% | +52.79% | +6.01% | +5.26% | +43.45% | -26.13% | -70.03% | +25285.45% | n/a |
| Research and Development Revenue | 4.68M | 4.15M | 4.19M | 3.93M | 3.97M | 3.42M | 3.15M | 3.84M | 3.09M | 4.73M | 3.69M | 3.18M | 4.7M | 4.05M | 3.42M | 3.1M | 2.46M | 3.55M | 1.75M | 2M | 2.53M | 2.59M | 2.43M | 2.01M | 1.78M | 1.99M | 1.79M | 1.95M | 1.93M | 2.27M | 1.86M | 1.41M | 1.93M | 1.91M | 1.74M | 1.91M | 1.02M | 1.23M | 890.5K | 835.2K |
| Research and Development Revenue Growth | +12.78% | -0.93% | +6.61% | -0.86% | +16.16% | +8.24% | -17.84% | +24.31% | -34.73% | +28.34% | +15.97% | -32.33% | +15.91% | +18.57% | +10.11% | +26.14% | -30.63% | +103.30% | -12.82% | -20.76% | -2.33% | +6.58% | +21.02% | +12.87% | -10.93% | +11.74% | -8.40% | +0.97% | -14.87% | +21.95% | +31.66% | -26.93% | +1.38% | +9.72% | -8.92% | +86.74% | -17.28% | +38.66% | +6.62% | n/a |